Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2026-02-10 @ 11:43 PM
Study NCT ID:
NCT01866657
Status:
TERMINATED
Last Update Posted:
2022-07-05
First Post:
2013-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000860', 'term': 'Hypoxia'}], 'ancestors': [{'id': 'D012818', 'term': 'Signs and Symptoms, Respiratory'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D014662', 'term': 'Vasoconstrictor Agents'}, {'id': 'D010656', 'term': 'Phenylephrine'}, {'id': 'D004809', 'term': 'Ephedrine'}, {'id': 'D004298', 'term': 'Dopamine'}, {'id': 'D000077149', 'term': 'Sevoflurane'}, {'id': 'D015742', 'term': 'Propofol'}], 'ancestors': [{'id': 'D002317', 'term': 'Cardiovascular Agents'}, {'id': 'D045506', 'term': 'Therapeutic Uses'}, {'id': 'D020228', 'term': 'Pharmacologic Actions'}, {'id': 'D020164', 'term': 'Chemical Actions and Uses'}, {'id': 'D004983', 'term': 'Ethanolamines'}, {'id': 'D000605', 'term': 'Amino Alcohols'}, {'id': 'D000438', 'term': 'Alcohols'}, {'id': 'D009930', 'term': 'Organic Chemicals'}, {'id': 'D000588', 'term': 'Amines'}, {'id': 'D011412', 'term': 'Propanolamines'}, {'id': 'D020005', 'term': 'Propanols'}, {'id': 'D010627', 'term': 'Phenethylamines'}, {'id': 'D005021', 'term': 'Ethylamines'}, {'id': 'D015306', 'term': 'Biogenic Monoamines'}, {'id': 'D001679', 'term': 'Biogenic Amines'}, {'id': 'D002395', 'term': 'Catecholamines'}, {'id': 'D002396', 'term': 'Catechols'}, {'id': 'D010636', 'term': 'Phenols'}, {'id': 'D001555', 'term': 'Benzene Derivatives'}, {'id': 'D006841', 'term': 'Hydrocarbons, Aromatic'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D008738', 'term': 'Methyl Ethers'}, {'id': 'D004987', 'term': 'Ethers'}, {'id': 'D006845', 'term': 'Hydrocarbons, Fluorinated'}, {'id': 'D006846', 'term': 'Hydrocarbons, Halogenated'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'Edwin.avery@uhhospitals.org', 'phone': '440-391-0690', 'title': 'Dr. Edwin Avery', 'organization': 'University Hospitals Cleveland Medical Center'}, 'certainAgreement': {'piSponsorEmployee': True}}, 'adverseEventsModule': {'timeFrame': 'Not collected', 'description': 'Adverse events data was not collected.', 'eventGroups': [{'id': 'EG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue", 'otherNumAtRisk': 0, 'deathsNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'deathsNumAffected': 0, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group.", 'otherNumAtRisk': 0, 'deathsNumAtRisk': 0, 'otherNumAffected': 0, 'seriousNumAtRisk': 0, 'deathsNumAffected': 0, 'seriousNumAffected': 0}], 'frequencyThreshold': '0'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'The Primary Objective of This Pilot Study is to Identify the Most Relevant Clinical Outcome Variables Which Significantly Diverge as a Result of Being Randomized to the Intervention Cohort vs. the Control Cohort.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'The clinical endpoints are defined by the clinical outcome variables assessed and include relationship of assignment group and AUC of cerebral desats and their observed relationship to PACU/hospital/ICU LOS, AUC of mean arterial blood pressure, IV vasoactive drugs, intraop mLs urine/kg/hr in OR, red blood cell(RBC) transfusion, change in surgical procedure, intra/postop stroke/TIA/MI/afib/AUC glucose \\> 110 mg/dL, OR time, narcotic administered in the OR, volume of crystalloid/colloid administered in the OR, Anti-emetic meds administered in the OR, Surgical procedure performed, Time on single lung ventilation, Intraop Use of epidural catheter, aldrete PACU score, frequency/severity of N/V in the PACU/ICU, mech vent time in the PACU/ICU, need for postop skilled nursing facility/rehab hospital, need for hospital readmission, change in MMSE/CAM scores from baseline, change in renal fxn compared to baseline, return of bowel function time, postop infection, postop composite endpoint', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to PACU Length of Stay.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group (i.e. control vs intervention group) to PACU LOS', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Area Under the Curve (AUC) of Cerebral Desaturations to PACU LOS', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC of cerebral desats to PACU LOS', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Hospital Length of Stay (HLOS)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One Year', 'description': 'Relationship of assignment group (i.e. control vs intervention group) to HLOS', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Area Under the Curve (AUC) of Cerebral Desaturations to HLOS', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of Area under the curve (AUC) of cerebral desaturations to HLOS', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to ICU LOS', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to ICU LOS', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to ICU LOS', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to ICU LOS', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to AUC of Mean Arterial Blood Pressure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One Year', 'description': 'Relationship of assignment group to AUC of mean arterial blood pressure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to AUC of Mean Arterial Blood Pressure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One Year', 'description': 'Relationship of AUC cerebral desaturations to AUC of mean arterial blood pressure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to AUC of Mean Arterial Blood Pressure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to AUC of mean arterial blood pressure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to AUC of Mean Arterial Blood Pressure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to AUC of mean arterial blood pressure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Intraoperative mLs Urine/kg/hr', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed intraoperative mLs urine/kg/hr', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Intraoperative mLs Urine/kg/hr', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed intraoperative mLs urine/kg/hr', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Transfusion of Red Blood Cells', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to transfusion of red blood cells', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Transfusion of Red Blood Cells', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to transfusion of red blood cells', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency of Any Change in Surgical Procedure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of any change in surgical procedure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Any Change in Surgical Procedure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of any change in surgical procedure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency of Intraoperative or Postoperative Stroke', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One Year', 'description': 'Relationship of assignment group to observed frequency of intraoperative or postoperative stroke', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Intraoperative or Postoperative Stroke', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of intraoperative or postoperative stroke', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency of Transient Ischemic Attack', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of transient ischemic attack', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Transient Ischemic Attack', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of transient ischemic attack', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency of Myocardial Infarction', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of myocardial infarction', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Myocardial Infarction', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of myocardial infarction', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency of Atrial Fibrillation', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of atrial fibrillation', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Atrial Fibrillation', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of atrial fibrillation', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency of AUC Glucose > 110 mg/dL', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of AUC glucose \\> 110 mg/dL', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of AUC Glucose > 110 mg/dL', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of AUC glucose \\> 110 mg/dL', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Operating Room Time', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed operating room time', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Operating Room Time', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed operating room time', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Amount of Narcotic Administered in the Operating Room', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed amount of narcotic administered in the operating room', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Amount of Narcotic Administered in the Operating Room', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed amount of narcotic administered in the operating room', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Volume of Crystalloid/Colloid Administered in the Operating Room', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed volume of crystalloid/colloid administered in the operating room', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Volume of Crystalloid/Colloid Administered in the Operating Room', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed volume of crystalloid/colloid administered in the operating room', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Amount of Anti-emetic Meds Administered in the Operating Room', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed amount of anti-emetic meds administered in the operating room', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Amount of Anti-emetic Meds Administered in the Operating Room', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed amount of anti-emetic meds administered in the operating room', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Reported Surgical Procedure Performed', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to reported surgical procedure performed', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Reported Surgical Procedure Performed', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to reported surgical procedure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Time on Single Lung Ventilation', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed time on single lung ventilation', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Time on Single Lung Ventilation', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed time on single lung ventilation', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Use of Epidural Catheter', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed use of epidural catheter', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Use of Epidural Catheter', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed use of epidural catheter', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Post Anesthesia Care Unit Aldrete Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed post anesthesia care unit Aldrete score', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Post Anesthesia Care Unit Aldrete Score', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed post anesthesia care unit Aldrete score', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Frequency and Severity of Nausea/Vomiting in the Post Anesthesia Care Unit/Intensive Care Unit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency and severity of nausea/vomiting in the post anesthesia care unit/intensive care unit', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Frequency and Severity of Nausea/Vomiting in the Post Anesthesia Care Unit/Intensive Care Unit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency and severity of nausea/vomiting in the post anesthesia care unit/intensive care unit', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Duration of Mechanical Ventilation in the Post Anesthesia Care Unit/Intensive Care Unit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed duration of mechanical ventilation in the post anesthesia care unit/intensive care unit', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Duration of Mechanical Ventilation in the Post Anesthesia Care Unit/Intensive Care Unit', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed duration of mechanical ventilation in the post anesthesia care unit/intensive care unit', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Need for Postoperative Discharge to Skilled Nursing/Rehabilitation Facility', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed need for postoperative discharge to skilled nursing/rehabilitation facility', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Need for Postoperative Discharge to Skilled Nursing/Rehabilitation Facility', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed need for postoperative discharge to skilled nursing/rehabilitation facility', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Need for Hospital Readmission', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed need for hospital readmission', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Need for Hospital Readmission', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed need for hospital readmission', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Change in CAM or MMSE Scores From Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed change in CAM or MMSE scores from baseline', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Change in CAM or MMSE Scores From Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed change in CAM or MMSE scores from baseline', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Change in Renal Function From Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed change in renal function from baseline', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Change in Renal Function From Baseline', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed change in renal function from baseline', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Time to Return of Bowel Function Time', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed time to return of bowel function time', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Time to Return of Bowel Function Time', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed time to return of bowel function time', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Group Assignment to Any Observed Postoperative Infection', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of group assignment to any observed postoperative infection', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Any Observed Postoperative Infection', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to any observed postoperative infection', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Time to Wean From Postoperative Supplemental Oxygen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed time to wean from postoperative supplemental oxygen', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Time to Wean From Postoperative Supplemental Oxygen', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed time to wean from postoperative supplemental oxygen', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of Assignment Group to Observed Incidence of Postop Morbidity Composite Endpoint (Defined in Description Section Below)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed incidence of postop morbidity composite endpoint (defined by having any 1 of the following: new onset afib, ≥Grade 2 PONV, HLOS≥4.5 days, PACU LOS≥2 hours, any infection, death, stroke, MI, greater 0.5 mg/dL increase in Cr or new need for renal dialysis, postop need for IV inotropes or vasoactive meds)', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'PRIMARY', 'title': 'Relationship of AUC Cerebral Desaturations to Observed Incidence of Postoperative Morbidity Composite Endpoint (Defined in Description Section Below)', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed incidence of postoperative morbidity composite endpoint (defined by having any one of the following: new onset atrial fibrillation, ≥Grade 2 PONV, HLOS≥4.5 days, PACU LOS≥2 hours, any infectious complication, death, stroke, myocardial infarction, greater 0.5 mg/dL increase in creatinine or new need for renal dialysis, postoperative need for intravenous inotropes or vasoactive medications)', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'SECONDARY', 'title': 'Assess the Frequency of Cerebral Desaturations in Both Cohorts by Examining Both the Total Number of Patients Experiencing Any Cerebral Desaturation as Well as the Total Number of Events Among Patients Experiencing Any Cerebral Desaturation.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Assess the frequency of cerebral desaturations in both the intervention and control cohorts by examining both the total number of patients experiencing any cerebral desaturation as well as the total number of events among patients experiencing any cerebral desaturation.', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'SECONDARY', 'title': 'Adverse Clinical Events and Serious Adverse Events Overall and in Each Cohort', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Assess the frequency of adverse clinical events and serious adverse events overall and in each cohort', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'SECONDARY', 'title': 'Perform a Comprehensive Assessment of the Frequency and Efficacy of Predefined rSO2 Desaturation Mitigation Interventions and Their Collective Ability to Affect the Observed Cerebral Oximetry Values.', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Perform a comprehensive assessment of the frequency and efficacy of predefined rSO2 desaturation mitigation interventions (e.g., increase MAP with IV vasoconstrictor or fluid bolus, normalize ETCO2, deepen anesthesia, etc.) and their collective ability to affect the observed cerebral oximetry values. This will allow determination of the average number of interventions required and those most commonly effective in mitigating desaturation.', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'SECONDARY', 'title': "Assess the Interventional Cohort's Preoperative Demographics and Collected Covariates for Association With the Ease or Difficulty of Mitigating Observed Cerebral Desaturation Events.", 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Because mitigating cerebral desaturations involves increasing oxygen delivery to the tissue it is possible that there is a relationship between preoperative demographic/variables such as age, peripheral vascular disease, left ventricular dysfunction, COPD, etc. and the ability to effectively mitigate desaturations in that subjects with disease in these organ systems may be more resistant to responding to desaturation interventions.', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': '• Logistic Regression Analysis to Determine the Most Relevant AUCrSO2 Desaturation Value(s) Associated With Any Detrimental Clinical Outcome(s) Monitored in This Study', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Logistic regression analysis to determine the most relevant AUCrSO2 desaturation value(s) associated with any detrimental clinical outcome(s) monitored in this study', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Logistic Regression Analysis to Determine the Most Relevant AUC Blood Pressure Values Associated With Any Detrimental Clinical Outcome(s) Monitored in This Study', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Logistic regression analysis to determine the most relevant AUC blood pressure values associated with any detrimental clinical outcome(s) monitored in this study', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Comparison of Baseline rSO2 Values (Room Air and Oxygen Supplemented) to All Collected Clinical Variables to Assess for Possibly Significant Associations', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'One year', 'description': 'Comparison of baseline rSO2 values (room air and oxygen supplemented) to all collected clinical variables to assess for possibly significant associations', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'Explore the Potential Impact of rSO2 Monitoring on Changing the Surgical Conduct of the Procedure', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}]}], 'groups': [{'id': 'OG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'OG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'timeFrame': 'one year', 'description': 'Explore the potential impact of rSO2 monitoring on changing the surgical conduct of the procedure', 'reportingStatus': 'POSTED', 'populationDescription': 'Data not collected'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'FG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '38'}, {'groupId': 'FG001', 'numSubjects': '36'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '36'}, {'groupId': 'FG001', 'numSubjects': '36'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}]}], 'dropWithdraws': [{'type': 'Surgery canceled', 'reasons': [{'groupId': 'FG000', 'numSubjects': '2'}, {'groupId': 'FG001', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '38', 'groupId': 'BG000'}, {'value': '36', 'groupId': 'BG001'}, {'value': '74', 'groupId': 'BG002'}]}], 'groups': [{'id': 'BG000', 'title': 'Intervention Cohort', 'description': "Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.\n\nVasoconstrictor Agents: cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.\n\nHead/neck repositioning: Assure that arterial and venous neck blood flow is not obstructed related to patient positioning\n\nIncrease ETCO2: Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery\n\nIV fluid bolus: Administer IV fluids to increase preload and cardiac output\n\nAdditional anesthesia: By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.\n\nRBC transfusion: By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity\n\nIncrease FiO2: Increase FiO2 to improve oxygen delivery to tissue"}, {'id': 'BG001', 'title': 'Blinded Cerebral Oximetry Monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}, {'id': 'BG002', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Categorical', 'classes': [{'categories': [{'title': '<=18 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Between 18 and 65 years', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}]}, {'title': '>=65 years', 'measurements': [{'value': '38', 'groupId': 'BG000'}, {'value': '35', 'groupId': 'BG001'}, {'value': '73', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '16', 'groupId': 'BG000'}, {'value': '21', 'groupId': 'BG001'}, {'value': '37', 'groupId': 'BG002'}]}, {'title': 'Male', 'measurements': [{'value': '22', 'groupId': 'BG000'}, {'value': '15', 'groupId': 'BG001'}, {'value': '37', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}]}, {'title': 'Black or African American', 'measurements': [{'value': '5', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '8', 'groupId': 'BG002'}]}, {'title': 'White', 'measurements': [{'value': '30', 'groupId': 'BG000'}, {'value': '32', 'groupId': 'BG001'}, {'value': '62', 'groupId': 'BG002'}]}, {'title': 'More than one race', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'documentSection': {'largeDocumentModule': {'largeDocs': [{'date': '2018-09-04', 'size': 319211, 'label': 'Study Protocol and Statistical Analysis Plan', 'hasIcf': False, 'hasSap': True, 'filename': 'Prot_SAP_000.pdf', 'typeAbbrev': 'Prot_SAP', 'uploadDate': '2022-05-19T10:56', 'hasProtocol': True}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['CARE_PROVIDER']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 74}}, 'statusModule': {'whyStopped': 'Funding', 'overallStatus': 'TERMINATED', 'startDateStruct': {'date': '2013-06', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-07', 'completionDateStruct': {'date': '2016-11-10', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2022-07-01', 'studyFirstSubmitDate': '2013-05-12', 'resultsFirstSubmitDate': '2022-06-07', 'studyFirstSubmitQcDate': '2013-05-28', 'lastUpdatePostDateStruct': {'date': '2022-07-05', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2022-07-01', 'studyFirstPostDateStruct': {'date': '2013-05-31', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2022-07-05', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2016-11-10', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': '• Logistic Regression Analysis to Determine the Most Relevant AUCrSO2 Desaturation Value(s) Associated With Any Detrimental Clinical Outcome(s) Monitored in This Study', 'timeFrame': 'one year', 'description': 'Logistic regression analysis to determine the most relevant AUCrSO2 desaturation value(s) associated with any detrimental clinical outcome(s) monitored in this study'}, {'measure': 'Logistic Regression Analysis to Determine the Most Relevant AUC Blood Pressure Values Associated With Any Detrimental Clinical Outcome(s) Monitored in This Study', 'timeFrame': 'one year', 'description': 'Logistic regression analysis to determine the most relevant AUC blood pressure values associated with any detrimental clinical outcome(s) monitored in this study'}, {'measure': 'Comparison of Baseline rSO2 Values (Room Air and Oxygen Supplemented) to All Collected Clinical Variables to Assess for Possibly Significant Associations', 'timeFrame': 'One year', 'description': 'Comparison of baseline rSO2 values (room air and oxygen supplemented) to all collected clinical variables to assess for possibly significant associations'}, {'measure': 'Explore the Potential Impact of rSO2 Monitoring on Changing the Surgical Conduct of the Procedure', 'timeFrame': 'one year', 'description': 'Explore the potential impact of rSO2 monitoring on changing the surgical conduct of the procedure'}], 'primaryOutcomes': [{'measure': 'The Primary Objective of This Pilot Study is to Identify the Most Relevant Clinical Outcome Variables Which Significantly Diverge as a Result of Being Randomized to the Intervention Cohort vs. the Control Cohort.', 'timeFrame': 'One year', 'description': 'The clinical endpoints are defined by the clinical outcome variables assessed and include relationship of assignment group and AUC of cerebral desats and their observed relationship to PACU/hospital/ICU LOS, AUC of mean arterial blood pressure, IV vasoactive drugs, intraop mLs urine/kg/hr in OR, red blood cell(RBC) transfusion, change in surgical procedure, intra/postop stroke/TIA/MI/afib/AUC glucose \\> 110 mg/dL, OR time, narcotic administered in the OR, volume of crystalloid/colloid administered in the OR, Anti-emetic meds administered in the OR, Surgical procedure performed, Time on single lung ventilation, Intraop Use of epidural catheter, aldrete PACU score, frequency/severity of N/V in the PACU/ICU, mech vent time in the PACU/ICU, need for postop skilled nursing facility/rehab hospital, need for hospital readmission, change in MMSE/CAM scores from baseline, change in renal fxn compared to baseline, return of bowel function time, postop infection, postop composite endpoint'}, {'measure': 'Relationship of Assignment Group to PACU Length of Stay.', 'timeFrame': 'One year', 'description': 'Relationship of assignment group (i.e. control vs intervention group) to PACU LOS'}, {'measure': 'Relationship of Area Under the Curve (AUC) of Cerebral Desaturations to PACU LOS', 'timeFrame': 'One year', 'description': 'Relationship of AUC of cerebral desats to PACU LOS'}, {'measure': 'Relationship of Assignment Group to Hospital Length of Stay (HLOS)', 'timeFrame': 'One Year', 'description': 'Relationship of assignment group (i.e. control vs intervention group) to HLOS'}, {'measure': 'Relationship of Area Under the Curve (AUC) of Cerebral Desaturations to HLOS', 'timeFrame': 'One year', 'description': 'Relationship of Area under the curve (AUC) of cerebral desaturations to HLOS'}, {'measure': 'Relationship of Assignment Group to ICU LOS', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to ICU LOS'}, {'measure': 'Relationship of AUC Cerebral Desaturations to ICU LOS', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to ICU LOS'}, {'measure': 'Relationship of Assignment Group to AUC of Mean Arterial Blood Pressure', 'timeFrame': 'One Year', 'description': 'Relationship of assignment group to AUC of mean arterial blood pressure'}, {'measure': 'Relationship of AUC Cerebral Desaturations to AUC of Mean Arterial Blood Pressure', 'timeFrame': 'One Year', 'description': 'Relationship of AUC cerebral desaturations to AUC of mean arterial blood pressure'}, {'measure': 'Relationship of Assignment Group to Observed Intraoperative mLs Urine/kg/hr', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed intraoperative mLs urine/kg/hr'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Intraoperative mLs Urine/kg/hr', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed intraoperative mLs urine/kg/hr'}, {'measure': 'Relationship of Assignment Group to Transfusion of Red Blood Cells', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to transfusion of red blood cells'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Transfusion of Red Blood Cells', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to transfusion of red blood cells'}, {'measure': 'Relationship of Assignment Group to Observed Frequency of Any Change in Surgical Procedure', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of any change in surgical procedure'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Any Change in Surgical Procedure', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of any change in surgical procedure'}, {'measure': 'Relationship of Assignment Group to Observed Frequency of Intraoperative or Postoperative Stroke', 'timeFrame': 'One Year', 'description': 'Relationship of assignment group to observed frequency of intraoperative or postoperative stroke'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Intraoperative or Postoperative Stroke', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of intraoperative or postoperative stroke'}, {'measure': 'Relationship of Assignment Group to Observed Frequency of Transient Ischemic Attack', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of transient ischemic attack'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Transient Ischemic Attack', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of transient ischemic attack'}, {'measure': 'Relationship of Assignment Group to Observed Frequency of Myocardial Infarction', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of myocardial infarction'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Myocardial Infarction', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of myocardial infarction'}, {'measure': 'Relationship of Assignment Group to Observed Frequency of Atrial Fibrillation', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of atrial fibrillation'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of Atrial Fibrillation', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of atrial fibrillation'}, {'measure': 'Relationship of Assignment Group to Observed Frequency of AUC Glucose > 110 mg/dL', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency of AUC glucose \\> 110 mg/dL'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency of AUC Glucose > 110 mg/dL', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency of AUC glucose \\> 110 mg/dL'}, {'measure': 'Relationship of Assignment Group to Observed Operating Room Time', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed operating room time'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Operating Room Time', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed operating room time'}, {'measure': 'Relationship of Assignment Group to Observed Amount of Narcotic Administered in the Operating Room', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed amount of narcotic administered in the operating room'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Amount of Narcotic Administered in the Operating Room', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed amount of narcotic administered in the operating room'}, {'measure': 'Relationship of Assignment Group to Observed Volume of Crystalloid/Colloid Administered in the Operating Room', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed volume of crystalloid/colloid administered in the operating room'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Volume of Crystalloid/Colloid Administered in the Operating Room', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed volume of crystalloid/colloid administered in the operating room'}, {'measure': 'Relationship of Assignment Group to Observed Amount of Anti-emetic Meds Administered in the Operating Room', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed amount of anti-emetic meds administered in the operating room'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Amount of Anti-emetic Meds Administered in the Operating Room', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed amount of anti-emetic meds administered in the operating room'}, {'measure': 'Relationship of Assignment Group to Reported Surgical Procedure Performed', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to reported surgical procedure performed'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Reported Surgical Procedure Performed', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to reported surgical procedure'}, {'measure': 'Relationship of Assignment Group to Observed Time on Single Lung Ventilation', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed time on single lung ventilation'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Time on Single Lung Ventilation', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed time on single lung ventilation'}, {'measure': 'Relationship of Assignment Group to Observed Use of Epidural Catheter', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed use of epidural catheter'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Use of Epidural Catheter', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed use of epidural catheter'}, {'measure': 'Relationship of Assignment Group to Observed Post Anesthesia Care Unit Aldrete Score', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed post anesthesia care unit Aldrete score'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Post Anesthesia Care Unit Aldrete Score', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed post anesthesia care unit Aldrete score'}, {'measure': 'Relationship of Assignment Group to Observed Frequency and Severity of Nausea/Vomiting in the Post Anesthesia Care Unit/Intensive Care Unit', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed frequency and severity of nausea/vomiting in the post anesthesia care unit/intensive care unit'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Frequency and Severity of Nausea/Vomiting in the Post Anesthesia Care Unit/Intensive Care Unit', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed frequency and severity of nausea/vomiting in the post anesthesia care unit/intensive care unit'}, {'measure': 'Relationship of Assignment Group to Observed Duration of Mechanical Ventilation in the Post Anesthesia Care Unit/Intensive Care Unit', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed duration of mechanical ventilation in the post anesthesia care unit/intensive care unit'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Duration of Mechanical Ventilation in the Post Anesthesia Care Unit/Intensive Care Unit', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed duration of mechanical ventilation in the post anesthesia care unit/intensive care unit'}, {'measure': 'Relationship of Assignment Group to Observed Need for Postoperative Discharge to Skilled Nursing/Rehabilitation Facility', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed need for postoperative discharge to skilled nursing/rehabilitation facility'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Need for Postoperative Discharge to Skilled Nursing/Rehabilitation Facility', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed need for postoperative discharge to skilled nursing/rehabilitation facility'}, {'measure': 'Relationship of Assignment Group to Observed Need for Hospital Readmission', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed need for hospital readmission'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Need for Hospital Readmission', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed need for hospital readmission'}, {'measure': 'Relationship of Assignment Group to Observed Change in CAM or MMSE Scores From Baseline', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed change in CAM or MMSE scores from baseline'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Change in CAM or MMSE Scores From Baseline', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed change in CAM or MMSE scores from baseline'}, {'measure': 'Relationship of Assignment Group to Observed Change in Renal Function From Baseline', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed change in renal function from baseline'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Change in Renal Function From Baseline', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed change in renal function from baseline'}, {'measure': 'Relationship of Assignment Group to Observed Time to Return of Bowel Function Time', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed time to return of bowel function time'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Time to Return of Bowel Function Time', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed time to return of bowel function time'}, {'measure': 'Relationship of Group Assignment to Any Observed Postoperative Infection', 'timeFrame': 'One year', 'description': 'Relationship of group assignment to any observed postoperative infection'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Any Observed Postoperative Infection', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to any observed postoperative infection'}, {'measure': 'Relationship of Assignment Group to Observed Time to Wean From Postoperative Supplemental Oxygen', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed time to wean from postoperative supplemental oxygen'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Time to Wean From Postoperative Supplemental Oxygen', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed time to wean from postoperative supplemental oxygen'}, {'measure': 'Relationship of Assignment Group to Observed Incidence of Postop Morbidity Composite Endpoint (Defined in Description Section Below)', 'timeFrame': 'One year', 'description': 'Relationship of assignment group to observed incidence of postop morbidity composite endpoint (defined by having any 1 of the following: new onset afib, ≥Grade 2 PONV, HLOS≥4.5 days, PACU LOS≥2 hours, any infection, death, stroke, MI, greater 0.5 mg/dL increase in Cr or new need for renal dialysis, postop need for IV inotropes or vasoactive meds)'}, {'measure': 'Relationship of AUC Cerebral Desaturations to Observed Incidence of Postoperative Morbidity Composite Endpoint (Defined in Description Section Below)', 'timeFrame': 'One year', 'description': 'Relationship of AUC cerebral desaturations to observed incidence of postoperative morbidity composite endpoint (defined by having any one of the following: new onset atrial fibrillation, ≥Grade 2 PONV, HLOS≥4.5 days, PACU LOS≥2 hours, any infectious complication, death, stroke, myocardial infarction, greater 0.5 mg/dL increase in creatinine or new need for renal dialysis, postoperative need for intravenous inotropes or vasoactive medications)'}], 'secondaryOutcomes': [{'measure': 'Assess the Frequency of Cerebral Desaturations in Both Cohorts by Examining Both the Total Number of Patients Experiencing Any Cerebral Desaturation as Well as the Total Number of Events Among Patients Experiencing Any Cerebral Desaturation.', 'timeFrame': 'one year', 'description': 'Assess the frequency of cerebral desaturations in both the intervention and control cohorts by examining both the total number of patients experiencing any cerebral desaturation as well as the total number of events among patients experiencing any cerebral desaturation.'}, {'measure': 'Adverse Clinical Events and Serious Adverse Events Overall and in Each Cohort', 'timeFrame': 'one year', 'description': 'Assess the frequency of adverse clinical events and serious adverse events overall and in each cohort'}, {'measure': 'Perform a Comprehensive Assessment of the Frequency and Efficacy of Predefined rSO2 Desaturation Mitigation Interventions and Their Collective Ability to Affect the Observed Cerebral Oximetry Values.', 'timeFrame': 'one year', 'description': 'Perform a comprehensive assessment of the frequency and efficacy of predefined rSO2 desaturation mitigation interventions (e.g., increase MAP with IV vasoconstrictor or fluid bolus, normalize ETCO2, deepen anesthesia, etc.) and their collective ability to affect the observed cerebral oximetry values. This will allow determination of the average number of interventions required and those most commonly effective in mitigating desaturation.'}, {'measure': "Assess the Interventional Cohort's Preoperative Demographics and Collected Covariates for Association With the Ease or Difficulty of Mitigating Observed Cerebral Desaturation Events.", 'timeFrame': 'one year', 'description': 'Because mitigating cerebral desaturations involves increasing oxygen delivery to the tissue it is possible that there is a relationship between preoperative demographic/variables such as age, peripheral vascular disease, left ventricular dysfunction, COPD, etc. and the ability to effectively mitigate desaturations in that subjects with disease in these organ systems may be more resistant to responding to desaturation interventions.'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'keywords': ['cerebral oximetry', 'randomized controlled pilot study', 'thoracic surgery', 'single lung ventilation'], 'conditions': ['Hypoxia']}, 'referencesModule': {'references': [{'type': 'BACKGROUND', 'citation': 'Avery EG. Cerebral oximetry is frequently a "first alert" indicator of adverse outcomes. White paper. October 2010. http://www.somanetics.com/images/stories/pdfs/white-paper-series.pdf Last accessed 08-05-2012'}, {'pmid': '16115985', 'type': 'BACKGROUND', 'citation': 'Casati A, Fanelli G, Pietropaoli P, Proietti R, Tufano R, Danelli G, Fierro G, De Cosmo G, Servillo G; Collaborative Italian Study Group on Anesthesia in Elderly Patients. Continuous monitoring of cerebral oxygen saturation in elderly patients undergoing major abdominal surgery minimizes brain exposure to potential hypoxia. Anesth Analg. 2005 Sep;101(3):740-747. doi: 10.1213/01.ane.0000166974.96219.cd.'}, {'pmid': '17179242', 'type': 'BACKGROUND', 'citation': 'Murkin JM, Adams SJ, Novick RJ, Quantz M, Bainbridge D, Iglesias I, Cleland A, Schaefer B, Irwin B, Fox S. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg. 2007 Jan;104(1):51-8. doi: 10.1213/01.ane.0000246814.29362.f4.'}, {'pmid': '22311364', 'type': 'BACKGROUND', 'citation': 'Tang L, Kazan R, Taddei R, Zaouter C, Cyr S, Hemmerling TM. Reduced cerebral oxygen saturation during thoracic surgery predicts early postoperative cognitive dysfunction. Br J Anaesth. 2012 Apr;108(4):623-9. doi: 10.1093/bja/aer501. Epub 2012 Feb 5.'}]}, 'descriptionModule': {'briefSummary': 'This is a prospective, randomized controlled pilot study of cerebral oximetry use in elderly patients undergoing thoracic surgical procedures that require the use of single lung ventilation. The hypothesis is that subjects randomized to open cerebral oximetry monitoring that have active intervention to mitigate observed desaturations will have measurable postoperative clinical outcome benefits when compared to the patients randomized to blinded cerebral oximetry monitoring with no active interventions to mitigate desaturations.', 'detailedDescription': "Study Rationale The use of bi-frontal, near infrared spectrophotometry (NIRS) based cerebral oximetry monitoring has been demonstrated to result in improved clinical outcomes in both general surgery patients and cardiac surgical patients using prospective, randomized controlled trial methodology. Elderly thoracic surgical patients undergoing procedures that involve single lung ventilation may also stand to benefit from the application of intraoperative and early postoperative NIRS cerebral oximetry monitoring. Cerebral oximetry has not been established as a standard of care monitoring modality in this patient population, thus permitting the application of randomized, controlled testing methodology to assess the potential impact of this monitoring modality upon these patients.\n\nHypothesis and Objectives:\n\nThe primary hypothesis in this pilot study of elderly thoracic surgical patients undergoing procedures involving single lung ventilation (SLV) is that there will be a measurable and significant clinical benefit (as assessed by a broad range of postoperative clinical outcome measures) to the subjects randomized to the intervention cohort (open bi-frontal NIRS based cerebral oximetry monitoring with a standardized intervention protocol) vs. the control cohort (blinded bi-frontal NIRS based cerebral oximetry monitoring).\n\nThe primary objective of this pilot study is to identify the most relevant clinical outcome variables which significantly diverge as a result of being randomized to the intervention cohort vs. the control cohort so that a larger, multicenter, prospective, randomized controlled clinical trial can be designed to further test the primary hypothesis as stated in the preceding section. The subsequent larger, multicenter trial will be conducted to definitively demonstrate the ability of INVOS® 5100 guided NIRS-based bi-frontal monitoring to improve clinical outcomes in this surgical patient group and potentially establish a new U.S. Food and Drug Administration cleared indication for this monitoring modality. The clinical outcome variables being assessed as the primary objective are many and a detailed list of these variables can be found in the OUTCOME MEASURES - Primary Outcome Measure Section of this submission.\n\nSecondary objectives of this pilot study include the following:\n\n1. Assess the frequency of cerebral desaturations in both the intervention and control cohorts by examining both the total number of patients experiencing any cerebral desaturation as well as the total number of events among patients experiencing any cerebral desaturation (of at least 5% below baseline and progressively larger desaturations). These analyses will be conducted on the entire study population as well as upon each cohort. The Area Under the Curve (AUC) analysis technique \\[incremental desaturation categories will be assessed based upon 5 to 50% decreases, measured in 5% increments, from established room air pre-incision baseline as well as oxygen supplemented pre-incision baseline as well as desaturations below absolute measured rSO2 values\\] will be employed to conduct these analyses.\n2. Assess the frequency of adverse clinical events and serious adverse events overall and in each cohort.\n3. Perform a comprehensive assessment of the frequency and efficacy of predefined rSO2 desaturation mitigation interventions and their collective ability to affect the observed cerebral oximetry values.\n4. Assess the interventional cohort's preoperative demographics and collected covariates for association with the ease or difficulty of mitigating observed cerebral desaturation events.\n\nExploratory analyses will include performing all possible comparisons of the two groups based upon all collected perioperative variables to examine the potentially significant relationships between the collected clinical variables representing surrogates of organ perfusion/function and cerebral oximetry desaturations (AUCrSO2). The following exploratory endpoints will be assessed:\n\n1. Logistic regression analysis to determine the most relevant AUCrSO2 desaturation value(s) associated with any detrimental clinical outcome(s) monitored in this study\n2. Logistic regression analysis to determine the most relevant AUC blood pressure values associated with any detrimental clinical outcome(s) monitored in this study\n3. Comparison of baseline rSO2 values (room air and oxygen supplemented) to all collected clinical variables to assess for possibly significant associations\n4. Explore the potential impact of rSO2 monitoring on changing the surgical conduct of the procedure Methodology: Single center, prospective, randomized, controlled clinical pilot study Number of Subjects: 100 subjects with balanced randomization (1:1) to control (blinded NIRS data) or intervention (open NIRS data) cohorts Main Criteria for Inclusion: Elderly patients (\\> 65 years of age) scheduled for a thoracic surgical procedure at UHCMC that will involve SLV.\n\nDuration of Treatment: Cerebral oximetry monitoring will begin with an assessment of both room air and oxygen supplemented bi-frontal baseline NIRS values and continue through the surgery to either PACU discharge or the initial 12 hours of post surgical ICU treatment. Mini Mental Status exam testing and Delirium testing with the Confusion Assessment Method will occur preoperatively and postoperatively through post-operative day (POD) #3 (or discharge if that occurs sooner than POD #3). Enrolled subjects will be followed during the index hospitalization and will undergo a 30 day follow up telephone interview to assess their progress following hospital discharge.\n\nCriteria for Evaluation:\n\nA large number of intraoperative and postoperative clinical variables that include cerebral oximetry, pulse oximetry, blood pressure, a composite outcome measure and clinical variables representing organ function will be assessed with the primary endpoint being the determination of which clinical variables are improved, if any, as a result of being randomized to open NIRS data monitoring with a predefined desaturation intervention algorithm guideline. The Mini Mental Status exam and Confusion Assessment Method test will be used to determine if any measured clinical variables have an effect upon neuropsychological outcomes. The frequency and effectiveness of the various cerebral desaturation mitigating interventions will be assessed in the intervention cohort.\n\nAdditional Safety Observations:\n\nThe frequency and severity of adverse clinical events and serious adverse clinical events will be assessed to determine if the use of open NIRS data bi-frontal cerebral monitoring is associated with any significant change in the observation of such events.\n\nStatistical Methods:\n\nPreoperative demographics and clinical variables will be compared in the two groups to assess for significant differences using the independent t-test. Differences in the observed clinical data between groups will be determined with the Wilcoxon rank-sum test. Stepwise, forward, multivariable logistic regression analysis will be performed to assess for relationships between cerebral desaturations and any of the measured clinical variables with a p value \\< 0.05 being considered significant"}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['OLDER_ADULT'], 'minimumAge': '65 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n1. Any male or female patient ≥ 65 years of age and able to provide informed consent (or consent may be provided by a legally authorized representative) who is scheduled for a thoracic surgical procedure that is expected to involve the use of intraoperative single lung ventilation (SLV)\n2. Able to adequately complete a baseline mini-mental status examination (MMSE)\n3. Able to complete a baseline confusion assessment method (CAM) examination\n4. Able to obtain bi-frontal baseline rSO2 values prior to induction of anesthesia\n\nExclusion Criteria:\n\n1. Any patient who has participated in a clinical study of an investigational drug or device in the past 30 days\n2. Any patient who the principal investigator feels at any time or for any reason should not participate in this clinical study\n3. Withdrawal of informed consent for any reason'}, 'identificationModule': {'nctId': 'NCT01866657', 'briefTitle': 'Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery', 'organization': {'class': 'OTHER', 'fullName': 'University Hospitals Cleveland Medical Center'}, 'officialTitle': 'NIRS-Based Cerebral Oximetry Monitoring in Elderly Thoracic Surgical Patients Undergoing Single Lung Ventilation Procedures: A Single Center, Prospective, Randomized Controlled Pilot Study Assessing the Clinical Impact of NIRS-Guided Intervention', 'orgStudyIdInfo': {'id': 'UHCMC-CEROX-01'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Intervention cohort', 'description': 'Open cerebral oximetry monitoring; observed desaturations will be treated with an intervention algorithm including increase FiO2, head/neck repositioning,vasoconstrictor agents, IV fluid bolus, increase ETCO2, additional anesthesia, RBC transfusion.', 'interventionNames': ['Drug: Vasoconstrictor Agents', 'Other: Head/neck repositioning', 'Other: Increase ETCO2', 'Other: IV fluid bolus', 'Drug: Additional anesthesia', 'Biological: RBC transfusion', 'Drug: Increase FiO2']}, {'type': 'NO_INTERVENTION', 'label': 'Blinded cerebral oximetry monitoring', 'description': "These subjects will have continous cerebral oximetry monitoring like the experimental cohort but the values will be blinded to all clinicians and research staff. There will be no cerebral desaturation interventions in this group because the clinicians will not be aware of a desaturation as the monitor's output is blinded in this group."}], 'interventions': [{'name': 'Vasoconstrictor Agents', 'type': 'DRUG', 'otherNames': ['phenylephrine, ephedrine, dopamine'], 'description': "cerebral desaturations may be treated with IV vasoactives to increase blood pressure or cardiac output at attending physician's descretion.", 'armGroupLabels': ['Intervention cohort']}, {'name': 'Head/neck repositioning', 'type': 'OTHER', 'otherNames': ['neck repositioning'], 'description': 'Assure that arterial and venous neck blood flow is not obstructed related to patient positioning', 'armGroupLabels': ['Intervention cohort']}, {'name': 'Increase ETCO2', 'type': 'OTHER', 'otherNames': ['Normalize end tidal CO2'], 'description': 'Allow normalization or slight increase in end tidal CO2 to cause selective cerebral vasodilation and increased tissue blood flow/O2 delivery', 'armGroupLabels': ['Intervention cohort']}, {'name': 'IV fluid bolus', 'type': 'OTHER', 'description': 'Administer IV fluids to increase preload and cardiac output', 'armGroupLabels': ['Intervention cohort']}, {'name': 'Additional anesthesia', 'type': 'DRUG', 'otherNames': ['sevoflurane, propofol'], 'description': 'By deepening anesthetic there will be a decrease in cerebral metabolic oxygen consumption.', 'armGroupLabels': ['Intervention cohort']}, {'name': 'RBC transfusion', 'type': 'BIOLOGICAL', 'description': 'By administering RBCs there will be a increase in intravascular volume and cardiac preload and an increase in oxygen carrying capacity', 'armGroupLabels': ['Intervention cohort']}, {'name': 'Increase FiO2', 'type': 'DRUG', 'otherNames': ['Increase fractional concentration of inspired oxygen'], 'description': 'Increase FiO2 to improve oxygen delivery to tissue', 'armGroupLabels': ['Intervention cohort']}]}, 'contactsLocationsModule': {'locations': [{'zip': '44126', 'city': 'Cleveland', 'state': 'Ohio', 'country': 'United States', 'facility': 'University Hospitals Case Medical Center', 'geoPoint': {'lat': 41.4995, 'lon': -81.69541}}], 'overallOfficials': [{'name': 'John C Klick, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University Hospitals Cleveland Medical Center'}, {'name': 'Edwin G Avery, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'University Hospitals Cleveland Medical Center'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University Hospitals Cleveland Medical Center', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}